VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor. Sci Transl Med. 2023 06 21; 15(701):eabq7839.
View in:
PubMed
subject areas
Animals
Arrhythmias, Cardiac
Calcium
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Child
Heart Diseases
Humans
Mice
Myocytes, Cardiac
Pyrazoles
authors with profiles
Lauren Edith Dorn
XANDER WEHRENS
MOHIT HULSURKAR